SAIL reported EBITDA of ₹2,767 crore for the quarter, marking a 24.7% increase from ₹2,219 crore in the corresponding period last year.
Interest earnings rose as well, reaching ₹31,003 crore, up from ₹28,701 crore in the corresponding quarter of FY25.
Alembic’s version is a generic substitute for Tegretol-XR, a medicine originally developed by Novartis.
The capital was infused via cash and will be used to support DRL Russia’s working capital requirements.
The net interest margin, however, declined. At 3.72%, it was lower than the 3.86% recorded in the March quarter.
The project will be executed at BEL’s Palasamudram unit in Andhra Pradesh and is expected to be completed over 24 months.
A quick look at the six key global and domestic signals over the last one week
Among the new projects is a 69.5 MW solar park by Prozeal Green Energy, which will come up in Biramaharajpur, located in Subarnapur district.
The previous tenure of the committee was scheduled to end on July 28.
As of June 30, the company’s net debt stood at ₹4,972 crore. This figure does not include ₹760 crore in lease liabilities.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
